(Registrieren)

EANS-News: LifeWatch AG to announce strong Third Quarter 2009 Results on November 5, 2009

Geschrieben am 08-10-2009

- Press release at 7:00 a.m. CET

- Analyst and media conference held in Zurich at 09:30 a.m. CET


--------------------------------------------------------------------------------
Corporate news transmitted by euro adhoc. The issuer/originator is solely
responsible for the content of this announcement.
--------------------------------------------------------------------------------


3-month report/Invitation analysts conference

Utl.: - Press release at 7:00 a.m. CET
- Analyst and media conference held in Zurich at 09:30 a.m. CET =

Neuhausen am Rheinfall (euro adhoc) - LifeWatch AG (SIX Swiss
Exchange:LIFE) announces its results for the third quarter 2009 on
November 5, 2009. As expected, business continues to develop
positively and LifeWatch AG will be able to report strong results for
the eighth consecutive quarter.

The PDF-Version of this invitation and a registration form can be
downloaded via the following links:
http://www.newsaktuell.ch/pdf/lifewatch_invite_q3_english_final.pdf
http://www.newsaktuell.ch/pdf/registration_form.pdf

Press Release at 7:00 a.m. CET (1:00 a.m. EST)

The results for the third quarter 2009 will be issued internationally
at 7:00 a.m. CET.

Analyst and Media conference

LifeWatch will report in detail on the third quarter 2009 results at
an English- speaking analyst and media conference which takes place
in Zurich on

Thursday, November 5, 2009; 09.30 a.m. CET, at the Zunfthaus
zur Saffran, Limmatquai 54, 8001 Zurich/Switzerland

Please confirm your participation at the analyst/media conference by
returning the attached registration form by November 2, 2009.

About LifeWatch AG

LifeWatch AG, headquartered in Neuhausen am Rheinfall and listed on
SIX Swiss Exchange (LIFE), Switzerland, is the leading healthcare
technology and solution company, specializing in advanced telehealth
systems and wireless cardiac monitoring services. LifeWatch services
treat high-risk and chronically ill patients, health conscious
consumers and wellness programs. LifeWatch has subsidiaries in the
United States, the Netherlands, Japan, the United Kingdom,
Switzerland and Israel. LifeWatch AG is the parent company of
LifeWatch Services Inc., a leading US-based cardiac monitoring
service provider, and LifeWatch Technologies Inc., a US-based
manufacturer of telecardiology products. www.lifewatch.com

Sign-up for customized E-mail alerts and documentation requests is
available at

http://production.investis.com/lifewatch/alert-service/

This press release includes forward-looking statements. All
statements other than statements of historical facts contained in
this press release, including statements regarding future results of
operations and financial position, business strategy and plans and
objectives for future operations, are forward- looking statements.
The words "believe," "may," "will," "estimate," "continue,"
"anticipate," "intend," "expect" and similar expressions are intended
to identify forward-looking statements. LifeWatch AG has based these
forward- looking statements largely on current expectations and
projections about future events and financial trends that it believes
may affect the financial condition, results of operations, business
strategy, short term and long term business operations and
objectives, and financial needs. These forward-looking statements are
subject to a number of risks, uncertainties and assumptions. In light
of these risks, uncertainties and assumptions, the forward-looking
events and circumstances described may not occur and actual results
could differ materially and adversely from those anticipated or
implied in the forward- looking statements. All forward-looking
statements are based only on data available to LifeWatch AG at the
time of the issue of this press release. LifeWatch AG does not
undertake any obligation to update any forward-looking statements
contained in this press release as a result of new information,
future events or otherwise.

THIS PRESS RELEASE IS NOT BEING ISSUED IN THE UNITED STATES OF
AMERICA AND SHOULD NOT BE DISTRIBUTED TO UNITED STATES PERSONS OR
PUBLICATIONS WITH A GENERAL CIRCULATION IN THE UNITED STATES. THIS
PRESS RELEASE DOES NOT CONSTITUTE AN OFFER OF SECURITIES OF LIFEWATCH
AG OR ANY OF ITS SUBSIDIARIES FOR SALE IN THE UNITED STATES OR AN
INVITATION TO SUBSCRIBE FOR OR PURCHASE ANY SECURITIES OF LIFEWATCH
AG OR ITS SUBSIDIARIES IN THE UNITED STATES. IN ADDITION, THE
SECURITIES OF LIFEWATCH AG AND ITS SUBSIDIARIES HAVE NOT BEEN
REGISTERED UNDER THE UNITED STATES SECURITIES LAWS AND MAY NOT BE
OFFERED, SOLD OR DELIVERED WITHIN THE UNITED STATES OR TO U.S.
PERSONS ABSENT REGISTRATION UNDER OR AN APPLICABLE EXEMPTION FROM THE
REGISTRATION REQUIREMENTS OF THE UNITED STATES SECURITIES LAWS. ANY
PUBLIC OFFERING OF SECURITIES TO BE MADE IN THE UNITED STATES WILL BE
MADE BY MEANS OF A PROSPECTUS THAT MAY BE OBTAINED FROM LIFEWATCH AG
OR ITS SUBSIDIARIES, AS APPLICABLE, AND WILL CONTAIN DETAILED
INFORMATION ABOUT THE ISSUER AND ITS MANAGEMENT AS WELL AS FINANCIAL
STATEMENTS OF THE ISSUER.


Ende der Mitteilung euro adhoc
--------------------------------------------------------------------------------


ots Originaltext: LifeWatch AG
Im Internet recherchierbar: http://www.presseportal.de

Further inquiry note:

Kobi Ben Efraim, Chief Financial Officer, LifeWatch AG

Tel +41 52 632 00 50 | Fax +41 52 632 00 51 | Email kobibe@lifewatch.com



Sensus Investor and Public Relations GmbH, Zürich:

Tel +41 43 366 55 11 | Fax +41 43 366 55 12 | Email lifewatch@sensus.ch

Branche: Healthcare Providers
ISIN: CH0012815459
WKN: 1281545
Index: SPI, SPIEX
Börsen: Frankfurt / Open Market / XETRA
SIX Swiss Exchange / Hauptsegment
Berlin / free trade


Kontaktinformationen:

Leider liegen uns zu diesem Artikel keine separaten Kontaktinformationen gespeichert vor.
Am Ende der Pressemitteilung finden Sie meist die Kontaktdaten des Verfassers.

Neu! Bewerten Sie unsere Artikel in der rechten Navigationsleiste und finden
Sie außerdem den meist aufgerufenen Artikel in dieser Rubrik.

Sie suche nach weiteren Pressenachrichten?
Mehr zu diesem Thema finden Sie auf folgender Übersichtsseite. Desweiteren finden Sie dort auch Nachrichten aus anderen Genres.

http://www.bankkaufmann.com/topics.html

Weitere Informationen erhalten Sie per E-Mail unter der Adresse: info@bankkaufmann.com.

@-symbol Internet Media UG (haftungsbeschränkt)
Schulstr. 18
D-91245 Simmelsdorf

E-Mail: media(at)at-symbol.de

229785

weitere Artikel:
  • EANS-Adhoc: Deutsche Effecten- und Wechsel-Beteiligungsges. AG / Wertberichtigung des Beteiligungsportfolios nach erstinstanzlichem Urteil für Integrated Genomics, Inc. -------------------------------------------------------------------------------- Ad-hoc-Meldung nach § 15 WpHG übermittelt durch euro adhoc mit dem Ziel einer europaweiten Verbreitung. Für den Inhalt ist der Emittent verantwortlich. -------------------------------------------------------------------------------- Eintrittsdatum: 08.10.2009 Das Portfoliounternehmen Integrated Genomics, Inc., Chicago/USA, unterlag gestern in erster Instanz vor dem Northern District Court of Illinois, Chicago im Rechtsstreit gegen Tillman Gerngross, dem mehr...

  • EANS-Adhoc: Deutsche Effecten- und Wechsel-Beteiligungsges. AG / Valuation Impairment of Investment Portfolio after First-Instance Judgement for Integrated Genomics, Inc. -------------------------------------------------------------------------------- ad-hoc disclosure pursuant to section 15 of the WpHG transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement. -------------------------------------------------------------------------------- date of causation: 08.10.2009 At the Northern District Court of Illinois, Chicago, the portfolio company Integrated Genomics, Inc., Chicago/USA yesterday lost its action against Tillman mehr...

  • EANS-News: Klöckner & Co SE: Gisbert Rühl übernimmt bereits am 1.11.2009 den Vorstandsvorsitz der Klöckner & Co SE -------------------------------------------------------------------------------- Corporate News übermittelt durch euro adhoc. Für den Inhalt ist der Emittent/Meldungsgeber verantwortlich. -------------------------------------------------------------------------------- Führungswechsel Duisburg (euro adhoc) - Duisburg, 8. Oktober 2009 - Der Aufsichtsrat der Klöckner & Co SE hat dem Wunsch von Dr. Thomas Ludwig entsprochen, ihn bereits zwei Monate früher als ursprünglich geplant, d.h. zum 31.10.2009, aus seinem Vertrag zu entlassen. Gleichzeitig mehr...

  • EANS-News: Klöckner & Co SE: Gisbert Rühl to become Chairman of the Management Board of Klöckner & Co SE already on November 1, 2009 -------------------------------------------------------------------------------- Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. -------------------------------------------------------------------------------- Management Changes Duisburg (euro adhoc) - Duisburg, October 8, 2009 - The Supervisory Board of Klöckner & Co SE has approved the request by Dr. Thomas Ludwig to resign two months earlier than initially planned on October 31, 2009. At the same time Gisbert mehr...

  • PetroCapitalResources - Management hat Prozedere für Aktiensplit eingeleitet und Einigkeit mit institutionellen Investoren erzielt London/Zürich (ots) - Die PetroCapital Resources (PCR) hat bekannt gegeben, dass das Prozedere für den angestrebten Aktiensplit eingeleitet wurde. Damit hat die PCR einen äußerst wichtigen Akt zur Unterstützung des Aktienkurses auf den Weg gebracht. Denn mit dieser strategischen Maßnahme wirkt das Management der PCR, wie bereits angekündigt, dem massiven Verkaufsdruck durch Leerverkäufer (Shorter) im Markt entgegen. Insgesamt 1,5 Millionen Stücke wurden zuletzt als Short Positionen verifiziert. Mit dem anstehenden Aktiensplit werden mehr...

Mehr zu dem Thema Finanzen

Der meistgelesene Artikel zu dem Thema:

Century Casinos wurde in Russell 2000 Index aufgenommen

durchschnittliche Punktzahl: 0
Stimmen: 0

Bitte nehmen Sie sich einen Augenblick Zeit, diesen Artikel zu bewerten:

Exzellent
Sehr gut
gut
normal
schlecht